Brief: Oncology Pharma, Kalos To Explore Anti-Cancer Drug For Covid-19
06/04/2020 13:40
April 6 (Reuters) - Oncology Pharma Inc ONPH.PK :
* ONCOLOGY PHARMA AND KALOS THERAPEUTICS EXPAND LICENSING
AGREEMENT FOR EXPLORING KALOS'S ANTI-CANCER LEAD DRUG IN
TREATING COVID-19
* SOURCINGLINK.NET INC - AMENDED TERMS OF THEIR
COLLABORATION TO
EXPLORE TREATMENT OPPORTUNITIES OF COVID-19 VIRUS
Source text for Eikon: ID:nGNX59T4Jf
Further company coverage: ONPH.PK
((Reuters.Briefs@thomsonreuters.com;))